1. Home
  2. EVO vs MLKN Comparison

EVO vs MLKN Comparison

Compare EVO & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • MLKN
  • Stock Information
  • Founded
  • EVO 1993
  • MLKN 1905
  • Country
  • EVO Germany
  • MLKN United States
  • Employees
  • EVO N/A
  • MLKN N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • MLKN Office Equipment/Supplies/Services
  • Sector
  • EVO Health Care
  • MLKN Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • MLKN Nasdaq
  • Market Cap
  • EVO 1.2B
  • MLKN 1.4B
  • IPO Year
  • EVO 2021
  • MLKN N/A
  • Fundamental
  • Price
  • EVO $3.73
  • MLKN $20.44
  • Analyst Decision
  • EVO Buy
  • MLKN
  • Analyst Count
  • EVO 2
  • MLKN 0
  • Target Price
  • EVO $5.40
  • MLKN N/A
  • AVG Volume (30 Days)
  • EVO 41.5K
  • MLKN 358.5K
  • Earning Date
  • EVO 11-05-2025
  • MLKN 09-23-2025
  • Dividend Yield
  • EVO N/A
  • MLKN 3.68%
  • EPS Growth
  • EVO N/A
  • MLKN N/A
  • EPS
  • EVO N/A
  • MLKN N/A
  • Revenue
  • EVO $912,894,891.00
  • MLKN $3,669,900,000.00
  • Revenue This Year
  • EVO $0.39
  • MLKN $4.74
  • Revenue Next Year
  • EVO $9.53
  • MLKN $3.64
  • P/E Ratio
  • EVO N/A
  • MLKN N/A
  • Revenue Growth
  • EVO N/A
  • MLKN 1.14
  • 52 Week Low
  • EVO $2.84
  • MLKN $15.25
  • 52 Week High
  • EVO $5.64
  • MLKN $28.33
  • Technical
  • Relative Strength Index (RSI)
  • EVO 57.04
  • MLKN 47.95
  • Support Level
  • EVO $3.43
  • MLKN $20.08
  • Resistance Level
  • EVO $3.55
  • MLKN $21.01
  • Average True Range (ATR)
  • EVO 0.08
  • MLKN 0.58
  • MACD
  • EVO 0.05
  • MLKN -0.14
  • Stochastic Oscillator
  • EVO 90.27
  • MLKN 25.84

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: